{
  "retracted": false,
  "timestamp": 1406764800000,
  "updates": [
    {
      "timestamp": 1550124061371,
      "identifier": {
        "doi": "10.1371/journal.pone.0105179"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1371/journal.pone.0096316"
  },
  "publisher": "Public Library of Science (PLoS)",
  "title": "Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example"
}
